CHTR vs EDIT
Charter Communications Inc (CHTR) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the CHTR and EDIT stock pages for the full models.
Not investment advice.